title: 1,3-Butadiene: linking metabolism, dosimetry, and mutation induction.
abstract: There is increasing concern for the potential adverse health effects of human exposures to chemical mixtures. To better understand the complex interactions of chemicals within a mixture, it is essential to develop a research strategy which provides the basis for extrapolating data from single chemicals to their behavior within the chemical mixture. 1,3-Butadiene (BD) represents an interesting case study in which new data are emerging that are critical for understanding interspecies differences in carcinogenic/genotoxic response to BD. Knowledge regarding mechanisms of BD-induced carcinogenicity provides the basis for assessing the potential effects of mixtures containing BD. BD is a multisite carcinogen in B6C3F1 mice and Sprague-Dawley rats. Mice exhibit high sensitivity relative to the rat to BD-induced tumorigenesis. Since it is likely that BD requires metabolic activation to mutagenic reactive epoxides that ultimately play a role in carcinogenicity of the chemical, a quantitative understanding of the balance of activation and inactivation is essential for improving our understanding and assessment of human risk following exposure to BD and chemical mixtures containing BD. Transgenic mice exposed to 625 ppm BD for 6 hr/day for 5 days exhibited significant mutagenicity in the lung, a target organ for the carcinogenic effect of BD in mice. In vitro studies designed to assess interspecies differences in the activation of BD and inactivation of BD epoxides reveal that significant differences exist among mice, rats, and humans. In general, the overall activation/detoxication ratio for BD metabolism was approximately 10-fold higher in mice compared to rats or humans.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina 27709.
authors.forename: J A
authors.initials: JA
authors.lastname: Bond
authors.forename: G A
authors.initials: GA
authors.lastname: Csanady
authors.forename: M L
authors.initials: ML
authors.lastname: Gargas
authors.forename: F P
authors.initials: FP
authors.lastname: Guengerich
authors.forename: T
authors.initials: T
authors.lastname: Leavens
authors.forename: M A
authors.initials: MA
authors.lastname: Medinsky
authors.forename: L
authors.initials: L
authors.lastname: Recio
mesh_terms: D000818:Animals; D001435:Bacteriophages / Q000235:genetics; D001554:Benzene / Q000378:metabolism; D002070:Butadienes / Q000378:metabolism* / Q000493:pharmacokinetics / Q000494:pharmacology; D004347:Drug Interactions; D000431:Ethanol / Q000378:metabolism; D006801:Humans; D008168:Lung / Q000648:ultrastructure; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D008861:Microsomes / Q000378:metabolism; D008862:Microsomes, Liver / Q000378:metabolism; D009154:Mutation; D051381:Rats; D017207:Rats, Sprague-Dawley; D013045:Species Specificity; D020058:Styrene; D013343:Styrenes / Q000378:metabolism
chemical_list: D002070:Butadienes; D013343:Styrenes; D000431:Ethanol; D020058:Styrene; D001554:Benzene; C031763:1,3-butadiene